 |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
|
Management
Stephen E. Pazian, Chairman, President and Chief Executive Officer of PRISMEDICAL, has over 20 years of diverse senior executive technology operations leadership experience leading multiple business units and start ups at the CEO level. Mr. Pazian has led organizations with no more than a concept to revenue generation and he has led businesses with over $300 million in annual revenues, 4000 employees and has led industries in profitability. He successfully engineered a major turn-around at BellSouth's MobileComm and grew Edison International's start up retail businesses from zero to $200 million revenue in two years. He has completed M&A transactions up to $945MM and has raised over one half billion dollars in capital to support various business initiatives. Mr. Pazian has served on three VC funded company boards and has participated on the division boards of BellSouth (a Fortune 50 Company now AT&T) including BellSouth Cellular (now AT&T Wireless) and BellSouth MobileComm.
Michael E. Taylor, PhD, Vice President, Research and Chief Science Officer. Dr. Taylor co-founded the company in 1996. He currently serves as the Chief Scientific Officer and Corporate Secretary. As CSO, Dr. Taylor provides assistance in strategic planning for the company. Dr. Taylor has been the originator and Principal Investigator of all of the Department of Defense Contracts from the Office of Naval Research. He is responsible for the Intellectual Properties, which includes 60 national and international issued and pending patents. Dr. Taylor received a Ph.D. in Microbiology and Immunology and a Master Degree in Pathology from the Medical College of Virginia. Prior to founding PRISMEDICAL, Dr. Taylor co-founded Sepratech. Prior to that, he held an academic research position at the Academic Cancer Center at the University of California, San Diego.
John Anes, Vice President of Engineering and Manufacturing for PRISMEDICAL, has over 25 years of experience in the development and manufacture of Health Care and Consumer Products systems, with specific experience in manufacture processes using injection molding, blow molding, rotation molding and resin compounding. He has directed the engineering and development groups for West Pharmaceutical Services for North America, a global pharmaceutical technology company that applies propriety material science to develop and manufacture pharmaceuticals, biologics, vaccines and consumer healthcare products. He has direct experience in the manufacturing and development of projects for the worlds leading pharmaceutical and consumer products companies, with project budgets up to $11,000,000. An example program was the development of injection molded packaging components for Abbott Laboratories Breakaway® Wet/Dry IV drug delivery system. John worked in product development and manufacturing for Container Corporation of America, in the manufacture of industrial and consumer containers and in Technical Sales for Shell Chemical Company, selling plastic resins for use in the compounding of high performance polymers. He is actively involved in working as a Technical Advisory Group (TAG) member for ANSI and ISO to standardize and harmonize the properties/performance of health care products to global standards.
Bill Stark, VP Sales and Marketing of PRISMEDICAL, has 25 years of sales and marketing expertise at buiding and managing distribution sales channels for fast growing companies. Bill's primary background includes sales and marketing management roles at AT&T and Verizon Wireless where he was instrumental in bringing cellular technology to the retail market in the US. Bill also served as VP of Retail at MobileComm Paging, a BellSouth owned two-way national paging firm. Bill has been PRISMEDICAL'S VP Sales and Marketing since 2006 and has helped the firm expand to new markets including outdoor retail, consumer emergency preparation and military sales. In his role, Bill works with PRISMEDICAL'S customers, resellers and VARs to develop sales through public safety, consumer, outdoor, travel and military channels.
Dr. Ewald Mueller, Corporate Controller of PRISMEDICAL, has more than 20 years of senior management career within the Pharmaceutical industry encompassing ethical, generic, and consumer health care products. Dr. Mueller has extensive experience within a research & development environment, provided strategic, business, financial & operating leadership to start-up enterprises, mergers, acquisitions, IPO, and high-growth divisions. His unique combination of scientific, business and financial acumen is backed by Ph.D. in Biology and Duke MBA.
As R&D controller Dr. Mueller was overseeing R&D budgets exceeding $250 million annually. He was a key player supporting the successful $1.5 billion IPO of Merck KGaA in his role as controller of the pharmaceutical division. For multiple international acquisitions, divestures, mergers, and business expansion projects exceeding several billion dollars, Dr. Mueller provided sound financial analysis facilitating the decision making process.
Michael E. Taylor, PhD, Vice President, Research and Chief Science Officer. Dr. Taylor co-founded the company in 1996. He currently serves as the Chief Scientific Officer and Corporate Secretary. As CSO, Dr. Taylor provides assistance in strategic planning for the company. Dr. Taylor has been the originator and Principal Investigator of all of the Department of Defense Contracts from the Office of Naval Research. He is responsible for the Intellectual Properties, which includes 60 national and international issued and pending patents. Dr. Taylor received a Ph.D. in Microbiology and Immunology and a Master Degree in Pathology from the Medical College of Virginia. Prior to founding PRISMEDICAL, Dr. Taylor co-founded Sepratech. Prior to that, he held an academic research position at the Academic Cancer Center at the University of California, San Diego.
John Anes, Vice President of Engineering and Manufacturing for PRISMEDICAL, has over 25 years of experience in the development and manufacture of Health Care and Consumer Products systems, with specific experience in manufacture processes using injection molding, blow molding, rotation molding and resin compounding. He has directed the engineering and development groups for West Pharmaceutical Services for North America, a global pharmaceutical technology company that applies propriety material science to develop and manufacture pharmaceuticals, biologics, vaccines and consumer healthcare products. He has direct experience in the manufacturing and development of projects for the worlds leading pharmaceutical and consumer products companies, with project budgets up to $11,000,000. An example program was the development of injection molded packaging components for Abbott Laboratories Breakaway® Wet/Dry IV drug delivery system. John worked in product development and manufacturing for Container Corporation of America, in the manufacture of industrial and consumer containers and in Technical Sales for Shell Chemical Company, selling plastic resins for use in the compounding of high performance polymers. He is actively involved in working as a Technical Advisory Group (TAG) member for ANSI and ISO to standardize and harmonize the properties/performance of health care products to global standards.
Bill Stark, VP Sales and Marketing of PRISMEDICAL, has 25 years of sales and marketing expertise at buiding and managing distribution sales channels for fast growing companies. Bill's primary background includes sales and marketing management roles at AT&T and Verizon Wireless where he was instrumental in bringing cellular technology to the retail market in the US. Bill also served as VP of Retail at MobileComm Paging, a BellSouth owned two-way national paging firm. Bill has been PRISMEDICAL'S VP Sales and Marketing since 2006 and has helped the firm expand to new markets including outdoor retail, consumer emergency preparation and military sales. In his role, Bill works with PRISMEDICAL'S customers, resellers and VARs to develop sales through public safety, consumer, outdoor, travel and military channels.
Dr. Ewald Mueller, Corporate Controller of PRISMEDICAL, has more than 20 years of senior management career within the Pharmaceutical industry encompassing ethical, generic, and consumer health care products. Dr. Mueller has extensive experience within a research & development environment, provided strategic, business, financial & operating leadership to start-up enterprises, mergers, acquisitions, IPO, and high-growth divisions. His unique combination of scientific, business and financial acumen is backed by Ph.D. in Biology and Duke MBA.
As R&D controller Dr. Mueller was overseeing R&D budgets exceeding $250 million annually. He was a key player supporting the successful $1.5 billion IPO of Merck KGaA in his role as controller of the pharmaceutical division. For multiple international acquisitions, divestures, mergers, and business expansion projects exceeding several billion dollars, Dr. Mueller provided sound financial analysis facilitating the decision making process.